Frelick Jeff has filed 6 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 16668 shares of Bone Biologics Corp ($BBLG) on January 08, 2026.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 8, 2026 | Bone Biologics Corp | $BBLG | Frelick Jeff | Chief Executive Officer | A | Employee Stock Option | 16668 | $0.00 | 25,695.0000 | 1,795,260 | 184.65% | 0.93% |
| Jan. 15, 2025 | Bone Biologics Corp | $BBLG | Frelick Jeff | Chief Executive Officer | A | Employee Stock Option | 54110 | $0.00 | 79,484.0000 | 0 | 213.25% | 0.00% |
| Jan. 17, 2024 | Bone Biologics Corp | $BBLG | Frelick Jeff | Chief Executive Officer | A | Employee Stock Option | 25000 | $0.00 | 25,582.0000 | 0 | 4295.53% | 0.00% |
| Sept. 11, 2023 | Bone Biologics Corp | $BBLG | Frelick Jeff | Chief Executive Officer | P | Common Stock | 9500 | $0.69 | 17,204.0000 | 0 | 123.31% | 0.00% |
| Aug. 31, 2023 | Bone Biologics Corp | $BBLG | Frelick Jeff | Chief Executive Officer | P | Common Stock | 7600 | $0.66 | 7,704.0000 | 0 | 7307.69% | 0.00% |
| Jan. 25, 2023 | Bone Biologics Corp | $BBLG | Frelick Jeff | Chief Executive Officer | A | Employee Stock Option | 37750 | $0.00 | 140,140.0000 | 0 | 36.87% | 0.00% |